Farnoosh Seirafianpour

No ORCID on file · 3 papers in corpus · active 2022-2024

Study types

  • review 1
2024
Evaluation of the Efficacy and Safety of Oral N-acetylcysteine in Patients With COVID-19 Receiving the Routine Antiviral and Hydroxychloroquine Protocol: A Randomized Controlled Clinical Trial
·doi:10.22541/au.170663924.40536518/v1

ABSTRACT The current absence of gold-standard or all-aspect favorable therapies for COVID-19 renders a focus on multipotential drugs proposed to prevent or treat this infection or ameliorate its signs and symptoms vitally important. The pre…

review 2024
Melatonin: Current evidence on protective and therapeutic roles in gynecological diseases
Life sciences ·doi:10.1016/j.lfs.2024.122557

Melatonin, a potent antioxidant and free radical scavenger, has been demonstrated to be effective in gynecological conditions and female reproductive cancers. This review consolidates the accumulating evidence on melatonin's multifaceted pr…

2022
A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.
Dermatologic therapy ·doi:10.1111/dth.15461

With dermatologic side effects being fairly prevalent following vaccination against COVID-19, and the multitude of studies aiming to report and analyze these adverse events, the need for an extensive investigation on previous studies seemed…